Pertumbuhan Lemah di Pasar Utamanya Terus Memberatkan Saham Bruker (BRKR)
· seekingalpha.com
Bruker Corporation menghadapi hambatan berkelanjutan dari lemahnya pendanaan akademik/pemerintah yang telah menekan pertumbuhan. Baca lebih lanjut tentang saham BRKR di sini.
The last few years have not been easy ones for the life sciences tools space. Not only has academic and government funding declined in many markets, but the ind...